ICOS antibody (APC)
Quick Overview for ICOS antibody (APC) (ABIN610261)
Target
See all ICOS AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recombinant and cell surface CD278 (ICOS).
-
Purification
- Gel filtration
-
Immunogen
- Human HPB-MLT cells, recombinant human CD278(ICOS)-muIg.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Approved: ELISA, Flo, Func
Usage: Function: Blocks binding of Recombinant CD275-muIg to CD278. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 500 mM potassium chloride, 150 mM sodium chloride, 15 % Glycerol, 0.2 % BSA, 0.04 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze. Product is photosensitive and should be protected from light.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C. Do not freeze. Protect from light.
-
-
-
Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis." in: Oncogene, Vol. 21, Issue 29, pp. 4539-48, (2002) (PubMed).
: "Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358." in: The Journal of biological chemistry, Vol. 277, Issue 7, pp. 4755-63, (2002) (PubMed).
: "
-
Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis." in: Oncogene, Vol. 21, Issue 29, pp. 4539-48, (2002) (PubMed).
-
- ICOS (Inducible T-Cell Co-Stimulator (ICOS))
-
Alternative Name
- ICOS / CD278
-
Background
-
Name/Gene ID: ICOS
Synonyms: ICOS, AILIM, CD278, CVID1, Inducible costimulator, Inducible T-cell co-stimulator, CD278 antigen, Inducible T-cell costimulator -
Gene ID
- 29851
-
UniProt
- Q9Y6W8
-
Pathways
- Cancer Immune Checkpoints
Target
-